More on IPXL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/6/15 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 163.09M
Short-term investments 0
Accounts receivable, net 180.31M
Inventory, net 121.12M
Deferred product manufacturing costs
Deferred income taxes 80.1M
Prepaid expenses and other current assets 53.5M
Total current assets 598.12M
Property, plant and equipment, net 215.59M
Deferred product manufacturing costs
Deferred income taxes, net 127K
Other assets 66.35M
Goodwill 152.05M
Total assets 1.78B
Current liabilities:
Accounts payable 49.34M
Accrued expenses 146.51M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 26.12M
Deferred revenue 3.92M
Total current liabilities 244.64M
Deferred revenue 3.18M
Other liabilities 38.55M
Total liabilities 887.94M
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 719K
Additional paid-in capital 373.98M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -3.11M
Retained earnings 524.89M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 894.33M
Total liabilities and stockholders' equity 1.78B